-
Je něco špatně v tomto záznamu ?
Adolescent exposure to benzophenone ultraviolet filters: cross-sectional associations with obesity, cardiometabolic biomarkers, and asthma/allergy in six European biomonitoring studies
FM. Peinado, A. Pérez-Cantero, A. Olivas-Martínez, L. Espín-Moreno, T. de Haro, LD. Boada, A. Rodríguez-Carrillo, E. Govarts, S. Pedraza-Díaz, M. Esteban-López, L. Blaha, L. Blahova, B. Janasik, W. Wasowicz, S. Lignell, L. Rambaud, M. Riou, C....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- alergie * epidemiologie MeSH
- benzofenony * toxicita moč škodlivé účinky MeSH
- biologické markery krev MeSH
- biologický monitoring MeSH
- bronchiální astma * epidemiologie chemicky indukované MeSH
- lidé MeSH
- mladiství MeSH
- obezita * epidemiologie chemicky indukované MeSH
- přípravky chránící proti slunci * škodlivé účinky MeSH
- průřezové studie MeSH
- vystavení vlivu životního prostředí * MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Exposure to benzophenone-1 (BP-1) and benzophenone-3 (BP-3), widely used as UV filters in personal care products, has been associated with adverse health effects. However, epidemiological evidence is limited and inconclusive, particularly in vulnerable populations such as teenagers. OBJECTIVE: To examine the relation between BP-1 and BP-3 concentrations and obesity, cardiometabolic biomarkers, and asthma/allergy outcomes in European teenagers, including possible sex-specific associations. METHODS: A multi-country cross-sectional study was conducted using pooled data from six aligned studies from the Human Biomonitoring for Europe Initiative (HBM4EU). Sociodemographic data, cardiometabolic biomarkers, and asthma/allergy outcomes were collected through questionnaires. Anthropometric data and BMI z-scores were calculated (n = 1339). Plasma/serum cardiometabolic biomarkers and asthma/allergy outcomes were available for a subsample (n = 173-594). Urinary BP-1 and BP-3 concentrations were adjusted for creatinine dilution using the traditional standardization (trad.) and the covariate-adjusted creatinine standardization (CAS) method. Generalized additive models, linear, logistic, and multinomial mixed models were applied, and sex-interaction terms were tested. RESULTS: Each natural log-unit increase in urinary BP-3 (CAS) concentrations was associated with higher odds of obesity in the whole population (OR: 1.20; 95%CI: 1.04-1.38). Sex-specific associations were also found with BP-1 (CAS) and BP-3 (CAS) concentrations, which were associated with higher odds of obesity in male teenagers (OR: 1.25; 95% CI: 1.01-1.55; OR: 1.34; 95%CI: 1.09-1.65, respectively). Linear mixed models showed consistent findings toward higher BMI z-scores. A negative association was found between BP-1 (CAS) concentration and serum adiponectin levels in females (% change per loge-unit increase: -3.73, 95%CI: -7.32, -0.10). BP-3 (CAS) concentrations were also associated with higher odds of non-food allergies in males (OR: 1.27; 95%CI: 1.00-1.63). Traditional creatinine adjustment showed similar or slightly attenuated estimates compared to the CAS method. CONCLUSIONS: BP-1 and BP-3 exposure was cross-sectionally associated with higher odds of obesity in European male teenagers, highlighting the need to update regulations and keep exposure levels as low as practically achievable. Longitudinal studies are needed to confirm these findings.
CIBER de Epidemiología y Salud Pública Spain
CIBER de Fisiopatología de la Obesidad y la Nutrición Spain
Department of Biomedical Sciences University of Antwerp Belgium
Department of Risk Benefit Assessment Swedish Food Agency Uppsala Sweden
German Environment Agency Berlin Germany
Instituto de Investigación Biosanitaria Granada Spain
National Centre for Environmental Health Instituto de Salud Carlos 3 Majadahonda Madrid Spain
RECETOX Faculty of Science Masaryk University Brno Czech Republic
Servicio de Radiodiagnóstico Hospital Universitario Clínico San Cecilio Granada Spain
Unidad de Gestión Clínica de Laboratorios Hospital Universitario Clínico San Cecilio Granada Spain
University of Granada Biomedical Research Center Granada Spain
VITO Health Flemish Institute for Technological Research 2400 Mol Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015097
- 003
- CZ-PrNML
- 005
- 20250731090749.0
- 007
- ta
- 008
- 250708e20250521ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.envres.2025.121912 $2 doi
- 035 __
- $a (PubMed)40409449
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Peinado, Francisco M $u University of Granada, Biomedical Research Center (CIBM), Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain
- 245 10
- $a Adolescent exposure to benzophenone ultraviolet filters: cross-sectional associations with obesity, cardiometabolic biomarkers, and asthma/allergy in six European biomonitoring studies / $c FM. Peinado, A. Pérez-Cantero, A. Olivas-Martínez, L. Espín-Moreno, T. de Haro, LD. Boada, A. Rodríguez-Carrillo, E. Govarts, S. Pedraza-Díaz, M. Esteban-López, L. Blaha, L. Blahova, B. Janasik, W. Wasowicz, S. Lignell, L. Rambaud, M. Riou, C. Fillol, S. Denys, A. Murawski, AL. Brantsæter, AK. Sakhi, N. Iszatt, G. Schoeters, M. Kolossa-Gehring, MF. Fernández, V. Mustieles
- 520 9_
- $a BACKGROUND: Exposure to benzophenone-1 (BP-1) and benzophenone-3 (BP-3), widely used as UV filters in personal care products, has been associated with adverse health effects. However, epidemiological evidence is limited and inconclusive, particularly in vulnerable populations such as teenagers. OBJECTIVE: To examine the relation between BP-1 and BP-3 concentrations and obesity, cardiometabolic biomarkers, and asthma/allergy outcomes in European teenagers, including possible sex-specific associations. METHODS: A multi-country cross-sectional study was conducted using pooled data from six aligned studies from the Human Biomonitoring for Europe Initiative (HBM4EU). Sociodemographic data, cardiometabolic biomarkers, and asthma/allergy outcomes were collected through questionnaires. Anthropometric data and BMI z-scores were calculated (n = 1339). Plasma/serum cardiometabolic biomarkers and asthma/allergy outcomes were available for a subsample (n = 173-594). Urinary BP-1 and BP-3 concentrations were adjusted for creatinine dilution using the traditional standardization (trad.) and the covariate-adjusted creatinine standardization (CAS) method. Generalized additive models, linear, logistic, and multinomial mixed models were applied, and sex-interaction terms were tested. RESULTS: Each natural log-unit increase in urinary BP-3 (CAS) concentrations was associated with higher odds of obesity in the whole population (OR: 1.20; 95%CI: 1.04-1.38). Sex-specific associations were also found with BP-1 (CAS) and BP-3 (CAS) concentrations, which were associated with higher odds of obesity in male teenagers (OR: 1.25; 95% CI: 1.01-1.55; OR: 1.34; 95%CI: 1.09-1.65, respectively). Linear mixed models showed consistent findings toward higher BMI z-scores. A negative association was found between BP-1 (CAS) concentration and serum adiponectin levels in females (% change per loge-unit increase: -3.73, 95%CI: -7.32, -0.10). BP-3 (CAS) concentrations were also associated with higher odds of non-food allergies in males (OR: 1.27; 95%CI: 1.00-1.63). Traditional creatinine adjustment showed similar or slightly attenuated estimates compared to the CAS method. CONCLUSIONS: BP-1 and BP-3 exposure was cross-sectionally associated with higher odds of obesity in European male teenagers, highlighting the need to update regulations and keep exposure levels as low as practically achievable. Longitudinal studies are needed to confirm these findings.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a benzofenony $x toxicita $x moč $x škodlivé účinky $7 D001577
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 12
- $a bronchiální astma $x epidemiologie $x chemicky indukované $7 D001249
- 650 12
- $a přípravky chránící proti slunci $x škodlivé účinky $7 D013473
- 650 _2
- $a biologický monitoring $7 D000079687
- 650 12
- $a obezita $x epidemiologie $x chemicky indukované $7 D009765
- 650 12
- $a alergie $x epidemiologie $7 D006967
- 650 12
- $a vystavení vlivu životního prostředí $7 D004781
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pérez-Cantero, Ainhoa $u University of Granada, Biomedical Research Center (CIBM), Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain
- 700 1_
- $a Olivas-Martínez, Alicia $u Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
- 700 1_
- $a Espín-Moreno, Lydia $u University of Granada, Biomedical Research Center (CIBM), Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
- 700 1_
- $a de Haro, Tomás $u Unidad de Gestión Clínica de Laboratorios, Hospital Universitario Clínico San Cecilio, Granada, Spain
- 700 1_
- $a Boada, Luis D $u Toxicology Unit, Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBERObn), Spain
- 700 1_
- $a Rodríguez-Carrillo, Andrea $u Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium
- 700 1_
- $a Govarts, Eva $u VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium
- 700 1_
- $a Pedraza-Díaz, Susana $u National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
- 700 1_
- $a Esteban-López, Marta $u National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
- 700 1_
- $a Blaha, Ludek $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Blahova, Lucie $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Janasik, Beata $u Nofer Institute of Occupational Medicine, Department of Environmental and Biological Monitoring, Poland
- 700 1_
- $a Wasowicz, Wojciech $u Nofer Institute of Occupational Medicine, Department of Environmental and Biological Monitoring, Poland
- 700 1_
- $a Lignell, Sanna $u Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
- 700 1_
- $a Rambaud, Loïc $u Department of Environmental and Occupational Health, Santé Publique France, French Public Health Agency (SpFrance), France
- 700 1_
- $a Riou, Margaux $u Department of Environmental and Occupational Health, Santé Publique France, French Public Health Agency (SpFrance), France
- 700 1_
- $a Fillol, Clémence $u Department of Environmental and Occupational Health, Santé Publique France, French Public Health Agency (SpFrance), France
- 700 1_
- $a Denys, Sébastien $u Department of Environmental and Occupational Health, Santé Publique France, French Public Health Agency (SpFrance), France
- 700 1_
- $a Murawski, Aline $u German Environment Agency (UBA), Berlin, Germany
- 700 1_
- $a Brantsæter, Anne Lise $u Department of Food Safety and Centre for Sustainable Diets, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Sakhi, Amrit Kaur $u Department of Food Safety and Centre for Sustainable Diets, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Iszatt, Nina $u Department of Food Safety and Centre for Sustainable Diets, Norwegian Institute of Public Health, Oslo, Norway
- 700 1_
- $a Schoeters, Greet $u Department of Biomedical Sciences, University of Antwerp, Belgium
- 700 1_
- $a Kolossa-Gehring, Marike $u German Environment Agency (UBA), Berlin, Germany
- 700 1_
- $a Fernández, Mariana F $u University of Granada, Biomedical Research Center (CIBM), Granada, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: marieta@ugr.es
- 700 1_
- $a Mustieles, Vicente $u Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain; Servicio de Radiodiagnóstico, Hospital Universitario Clínico San Cecilio, Granada, Spain
- 773 0_
- $w MED00001557 $t Environmental research. Section A $x 1096-0953 $g Roč. 280 (20250521), s. 121912
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40409449 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090742 $b ABA008
- 999 __
- $a ok $b bmc $g 2366153 $s 1252222
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 280 $c - $d 121912 $e 20250521 $i 1096-0953 $m Environmental research. Section A $n Environ Res $x MED00001557
- LZP __
- $a Pubmed-20250708